LpxC Inhibitors With Fluoroproline As A Novel Zinc-Binding Group Can Serve As A Novel Class of Antibiotic With Activity Against Multidrug-Resistant Gram-Negative Bacteria
Ryan, M.D., Pallin, T.D., Mullins, T., Blench, T., Fraser, I., Dallow, J., Ahmed, N., Ellwood, C., Gaines, S., Flores, J., Blackwell, Y., Garcia, C.T., Spence, G., Reeve, A., Panchal, T., Dominguez-Fernandez, B., Leonard, P.M., Lamers, M.B.A.C., Arduin, A., Fotinou, C., Gancia, E., Clark, D.E., Bush, E., Betts, J., Richards, C., Rea-Davies, T., Keefe, A.D., Zhang, Y., Soutter, H.T., Centrella, P.A., Clark, M.A., Cuozzo, J.W., Dumelin, C.E., Habeshian, S., Hunt, A., Sigel, E.A., Troast, D.M., DeJonge, B.L.M.To be published.